| Financial Year |
March 31 2023 |
| Monetary Funds |
279,940,960.01 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
50,008,171.51 |
| Accounts Receivable |
295,279,309.90 |
| Advances to Suppliers |
2,691,269.99 |
| Other Receivables |
6,432,706.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,140,180.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,716,704.00 |
| Total Current Assets |
1,067,298,024.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,735,939.27 |
| Investment Properties |
-- |
| Fixed Assetes |
404,468,660.85 |
| Under-construction Projects |
196,918,900.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
17,143,974.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,808,567.58 |
| Deferred Income Tax Assets |
34,665,820.47 |
| Other Non-Current Assets |
11,724,457.17 |
| Sub-Total of Non-Current Assets |
708,368,569.71 |
| Total Assets |
1,775,666,593.97 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
149,037,785.45 |
| Accounts Payable |
332,361,275.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,637,668.69 |
| Taxes Payable |
1,286,908.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,021,060.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,027,784.04 |
| Other Current Liabilities |
23,013,743.60 |
| Sub-Total of Current Liabilities |
580,786,953.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,825,236.55 |
| Other Non-Current Liabilities |
27,928,320.78 |
| Sub-Total of Non-Current Liabilities |
53,244,506.95 |
| Total Liabilities |
634,031,460.48 |
| Paid-In Capital(Or Share Stock) |
175,796,000.00 |
| Capital Surplus |
594,236,551.06 |
| Surplus Reserve |
20,321,127.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
349,319,860.72 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,141,635,133.49 |
| Owner's Equity（Stockholder's Equity） |
1,141,635,133.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,775,666,593.97 |
